Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

248. Glucose transporter type 1 deficiency Disease details / Clinical trials / Drug dev / DR info /

Clinical trials : 29 / Drugs : 8 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

GLUT1 DS
   Institut National de la Santé Et de la Recherche Médicale, France
      2013   Phase 2   NCT02014883   France
Ketoflo
   Vitaflo International, Ltd
      2020   -   NCT04399954   United Kingdom
Keyo
   Vitaflo International, Ltd
      2016   -   NCT02915211   United Kingdom
Krio
   Vitaflo International, Ltd
      2018   -   NCT03202108   United Kingdom
Triheptanoin
   Adrian Lacy
      2014   Phase 2   NCT02036853   United States
   Jerry Vockley, MD, PhD
      2017   -   NCT02968953   United States
   Juan Pascual
      2017   Phase 1   NCT03041363   United States
      2015   Phase 1/Phase 2   NCT02021526   United States
      2013   -   NCT02018302   United States
      2012   Phase 1   NCT02018315   United States
   Ultragenyx Pharmaceutical Inc
      2017   Phase 3   EUCTR2015-005536-17-GB   Australia;France;Germany;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-FR   Australia;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-ES   Australia;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-DE   Australia;France;Germany;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-000389-69-GB   Australia;Denmark;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-000389-69-ES   Australia;Denmark;France;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-000389-69-DK   Australia;Denmark;Israel;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2013-003771-35-DK   Australia;Denmark;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2013-003771-35-HU   Australia;Denmark;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003771-35-GB   Denmark;France;Hungary;Italy;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003771-35-IT   Denmark;France;Hungary;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 2   EUCTR2013-003771-35-FR   Denmark;France;Hungary;Italy;Spain;United Kingdom;United States
   University of British Columbia
      2014   Phase 2   NCT02000960   Canada
   University of Texas Southwestern Medical Center
      2018   Phase 2   NCT03301532   United States
      2018   Phase 2   NCT03181399   United States
Triheptanoin / triheptanoina
   Ultragenyx Pharmaceutical Inc
      2015   Phase 2   EUCTR2013-003771-35-ES   Denmark;France;Hungary;Italy;Spain;United Kingdom;United States
Triheptanoina
   Ultragenyx Pharmaceutical Inc
      2017   Phase 2   EUCTR2015-000389-69-ES   Australia;Denmark;France;Israel;Italy;Spain;United Kingdom;United States
UX007
   Ultragenyx Pharmaceutical Inc
      2017   Phase 3   NCT02960217   France;Germany;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-GB   Australia;France;Germany;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-FR   Australia;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-ES   Australia;France;Germany;Ireland;Israel;Italy;Netherlands;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005536-17-DE   Australia;France;Germany;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-000389-69-GB   Australia;Denmark;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-000389-69-ES   Australia;Denmark;France;Israel;Italy;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-000389-69-DK   Australia;Denmark;Israel;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2013-003771-35-DK   Australia;Denmark;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2013-003771-35-HU   Australia;Denmark;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2015   Phase 2   NCT02599961   Australia;Denmark;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003771-35-GB   Denmark;France;Hungary;Italy;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003771-35-ES   Denmark;France;Hungary;Italy;Spain;United Kingdom;United States
      2014   Phase 2   NCT01993186   Australia;France;Hungary;Israel;Italy;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003771-35-IT   Denmark;France;Hungary;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 2   EUCTR2013-003771-35-FR   Denmark;France;Hungary;Italy;Spain;United Kingdom;United States